Navigation Links
Rib-X Pharmaceuticals to Present at Cambridge Healthtech Institute's 2nd Annual Challenge of Antibacterial Development Conference
Date:4/22/2008

izes on its proprietary high-resolution crystal structure of the ribosome, which performs an essential role in the fundamental process of protein synthesis. Many known, commercially valuable antibiotics bind to the ribosome, including those used to treat both community-acquired and hospital-acquired pathogens. The Company's integrated research strategy, which combines state of the art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative intelligent engine has yielded several distinctive new antibiotic classes. The Company currently has two programs in human clinical trials, the RX-1741 designer oxazolidinone program as an oral/IV agent to treat serious hospital Gram-positive infections and the RX-3341 program, a next generation fluoroquinolone, active against a broad spectrum of bacteria, including methicillin-resistant Staphylococcus aureus. Additionally, the Company has multiple drug discovery programs. The first of these programs is focused on design and development of an orally active macrolide for community use for treatment of skin infections, including those caused by MRSA. The second discovery program is directed towards identifying a new chemical class of antibiotics active against multi-drug resistant Gram-negative bacteria.

For more information on the ribosome and the Rib-X mission, please visit the Company website at http://www.rib-x.com.


'/>"/>
SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
2. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of the American Association for Cancer Research (AACR); Scientific Advisory Board Chairman Tyler Jacks Named President-elect
3. Paratek Pharmaceuticals Completes $40 Million Private Placement to Finance Clinical Programs Including Oral Antibiotic to Combat MRSA and Other Infections
4. Vion Pharmaceuticals Files Plan With Nasdaq
5. Amylin Pharmaceuticals to Webcast First Quarter Results
6. Paloma Pharmaceuticals to Present at the American Association for Cancer Research
7. Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
8. Peregrine Pharmaceuticals Announces Four Upcoming Presentations at the American Association for Cancer Research 2008 Annual Meeting
9. Pharmaceuticals & Biotechs to Share Insights for Developing Leaders in a Fast-Paced, Competitive Industry
10. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
11. Diffusion Pharmaceuticals Announces Issuance of U.S. Patent No. 7351844, Titled Bipolar Trans Carotenoid Salts and Their Uses, for Its Family of First-In-Class Molecules
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... ALTO, Calif. , April 17, 2015 ... has received a SBIR grant from the ... the National Institutes of Health (NIH). The ... research efforts in the development of breakthrough ... genomes using specially fabricated substrates. Centrillion has ...
(Date:4/17/2015)... 17, 2015 Reed Technology and ... regulatory data management, preparation, and submission to the U.S. ... of a new Lot Distribution Report (LDR) service for ... remain compliant with the FDA’s new rule on electronic ... to monitor the volume and timing of particular biologics ...
(Date:4/17/2015)... CIO Review ( http://www.cioreview.com ) has chosen MMIS ... and Life Science Technology Solution Providers 2015. The positioning ... for life sciences companies. , The annual list ... and members of CIO Review’s editorial board to recognize ... on our radar for some time now for stirring ...
(Date:4/17/2015)... April 17, 2015 /PRNewswire/ - SQI Diagnostics Inc. (TSX-V: ... company that develops and commercializes proprietary technologies and ... that it has received approval from the TSX ... outstanding common share purchase warrants ("the Warrants") of ... the Company,s May 2013 private placement financing. ...
Breaking Biology Technology:Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 3MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2SQI Diagnostics to Extend Warrant Expiry 2SQI Diagnostics to Extend Warrant Expiry 3
... (Nasdaq: ITMN ) today announced additions to ... of Esbriet™ (pirfenidone) in Europe.  InterMune,s Marketing Authorization Application ... is now awaiting ratification by the European Commission. ... of InterMune, said, "We are very pleased by the ...
... Dec. 17, 2010 RIFM, through its sponsorship of ... announce the resulting paper, Integrating population modeling into ... al , published in Integrated Environmental Assessment and Management ... of this journal according to Wiley-Blackwell and SETAC, publishers, ...
... from the Institut Catal de Nanotecnologia (ICN), in Barcelona, has ... electric currents, a key step in developing the spin computers ... 17 issue of the journal Science. The authors are Marius ... is leader of the Physics and Engineering of Nanodevices Group ...
Cached Biology Technology:InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe 2InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe 3InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe 4InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe 5InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet™ (Pirfenidone) in Europe 6RIFM Co-Authors Environmental Article - Among Top 5 Most Downloaded 2A 'spin ratchet': A new electronic structure for generating spin current 2
(Date:4/17/2015)... Canada , April 17, 2015 ... growing security concerns, and technological advancement to drive ... until 2020   According ... Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems ... is projected to register growth at CAGR of ...
(Date:4/14/2015)...  HYPR Corp. today announced it has joined ... tm , an industry consortium transforming online authentication ... technology and collaborate to deliver open specifications for ... and private, and easier to use. ... sensitive user information and eliminates the dependency on ...
(Date:4/14/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... New York Design Awards under the category  ,Product Design ... Design Awards are part of a global multi-disciplinary awards ... from the marketplace, industry and judging panel. Winners will ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... Georgetown Lombardi Comprehensive Cancer Center, part of Georgetown University ... Cancer or G-DOC. Under development for two ... normally only available in scattered information libraries and tissue banks, ... new information. G-DOC also contains relevant tools to analyze ...
... For the first time, scientists have discovered that a poorly ... a respiratory virus attack may affect the outcome of the ... , a journal of the American Society for Microbiology. ... manual, its DNA. The best known of these RNAs ...
... Periodontitis, a common inflammatory disease in which gum tissue ... potential bone and tooth loss. Although traditional treatments concentrate ... inflammatory response. In an article in the November issue ... , researchers from Harvard Medical School and Harvard School ...
Cached Biology News:Unique database of cancer -- designed to personalize treatment -- is launched 2Unique database of cancer -- designed to personalize treatment -- is launched 3Unique database of cancer -- designed to personalize treatment -- is launched 4New class of biomolecules triggered in response to respiratory virus infection 2New class of biomolecules triggered in response to respiratory virus infection 3New class of biomolecules triggered in response to respiratory virus infection 4Consuming polyunsaturated fatty acids may lower the incidence of gum disease 2
Request Info...
Highly sensive assay for detecting apoptosis in living cells. See detailed descriptions above in K250-25....
... Z-Competent E. coli Transformation Buffer Set are ... E. coli cells for simple and highly ... eliminates the requirement for heat shocking and ... be performed by adding DNA to Z-Competent ...
... SizeSep 400 Spun Columns, 10. *SizeSep 400 ... > 400 base pairs in length. ... CL-4B and pre-equilibrated in distilled water containing 0.15% ... than ~ 400 base pairs. *Extremely ...
Biology Products: